Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

276 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.
Warde P, Mason M, Ding K, Kirkbride P, Brundage M, Cowan R, Gospodarowicz M, Sanders K, Kostashuk E, Swanson G, Barber J, Hiltz A, Parmar MK, Sathya J, Anderson J, Hayter C, Hetherington J, Sydes MR, Parulekar W; NCIC CTG PR.3/MRC UK PR07 investigators. Warde P, et al. Among authors: brundage m. Lancet. 2011 Dec 17;378(9809):2104-11. doi: 10.1016/S0140-6736(11)61095-7. Epub 2011 Nov 2. Lancet. 2011. PMID: 22056152 Free PMC article. Clinical Trial.
The prostate cancer risk stratification (ProCaRS) project: recursive partitioning risk stratification analysis.
Rodrigues G, Lukka H, Warde P, Brundage M, Souhami L, Crook J, Cury F, Catton C, Mok G, Martin AG, Vigneault E, Morris J, Warner A, Gonzalez Maldonado S, Pickles T; Genitourinary Radiation Oncologists of Canada (GUROC). Rodrigues G, et al. Among authors: brundage m. Radiother Oncol. 2013 Nov;109(2):204-10. doi: 10.1016/j.radonc.2013.07.020. Epub 2013 Nov 11. Radiother Oncol. 2013. PMID: 24231239
Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial.
Brundage M, Sydes MR, Parulekar WR, Warde P, Cowan R, Bezjak A, Kirkbride P, Parliament M, Moynihan C, Bahary JP, Parmar MK, Sanders K, Chen BE, Mason MD. Brundage M, et al. J Clin Oncol. 2015 Jul 1;33(19):2151-7. doi: 10.1200/JCO.2014.57.8724. Epub 2015 May 26. J Clin Oncol. 2015. PMID: 26014295 Free PMC article. Clinical Trial.
Predictive model for survival in patients having repeat radiation treatment for painful bone metastases.
Chow E, Ding K, Parulekar WR, Wong RK, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JS, Nabid A, Leer JW, Vonk E, Babington S, Demas WF, Wilson CF, Brundage M, Zhu L, Meyer RM. Chow E, et al. Among authors: brundage m. Radiother Oncol. 2016 Mar;118(3):547-51. doi: 10.1016/j.radonc.2015.10.018. Epub 2015 Oct 26. Radiother Oncol. 2016. PMID: 26515411 Clinical Trial.
The Canadian National System for Incident Reporting in Radiation Treatment (NSIR-RT) Taxonomy.
Milosevic M, Angers C, Liszewski B, Drodge CS, Marchand EL, Bissonnette JP, Brown E, Dunscombe P, Hunt J, Jiang H, Louie K, Mitera G, Moran K, Panzarella T, Parliament M, Ross S, Brundage M. Milosevic M, et al. Among authors: brundage m. Pract Radiat Oncol. 2016 Sep-Oct;6(5):334-341. doi: 10.1016/j.prro.2016.01.013. Epub 2016 Jan 30. Pract Radiat Oncol. 2016. PMID: 27068779
276 results